Theratechnologies Inc T.TH

Institutional investor buying

[scarlet1967]

Stifel Financial Corp reports 7.49% increase in ownership of THTX / Theratechnologies Inc.

2021-08-13 - Stifel Financial Corp has filed a 13F-HR form disclosing ownership of 256,236 shares of Theratechnologies Inc. (US:THTX) with total holdings valued at $994,000 USD as of 2021-06-30. Stifel Financial Corp had filed a previous 13F-HR on 2021-05-14 disclosing 238,386 shares of Theratechnologies Inc. at a value of $921,000 USD. This represents a change in shares of 7.49 percent and a change in value of 7.93 percent during the quarter.

Price per share $3.87.

 

https://fintel.io/so/us/thtx/stifel-financial

 

UBS Group AG reports 16.04% increase in ownership of THTX / Theratechnologies Inc.

2021-08-13 - UBS Group AG has filed a 13F-HR form disclosing ownership of 87,144 shares of Theratechnologies Inc. (US:THTX) with total holdings valued at $338,000 USD as of 2021-06-30. UBS Group AG had filed a previous 13F-HR on 2021-05-12 disclosing 75,101 shares of Theratechnologies Inc. at a value of $290,000 USD. This represents a change in shares of 16.04 percent and a change in value of 16.55 percent during the quarter.

Price per share $3.87.

 

https://fintel.io/so/us/thtx/ubs

[Bucknelly21]

So institutes adding but someone is selling at the same time.... price is stagnant 

[scarlet1967]

Last time the price was at $3.87 was more than a month ago. The sellers again are unmotivated retail investors. So longtime shareholders paying the price because the company is reluctant so far to address this ongoing issue.

[SPCEO1]

I don't think that $3.87 price is the price they bought at. I suspect it is the price at the end of June which is date of when the filing was due. It is nice to see a little buying by institutions but it is quite tiny. And that is to be expected since the market cap of the stock is so small and the share price is below $5 per share. Both are huge limitations to institutional buying. Yet as

[scarlet1967]

I get it, they want to bring institutions onboard which is great but nothing on retail front when almost 60% of trading is done by retail investors doesn't make sense. Sesen for instance has about 37k followers on Stocktwits, multiple posts every minute now worth over  $1.1 B. Looking at their website they have monthly business updates. So why not approaching that opportunity at all? 

[qwerty22]

Yes and you just posted a news report about Taimed from a website that seems to suggest Taimed has 18,000 follower there. What is that doing for Taimed's stock price? Sesen is on a roll because people see an approval coming. Thtx was on a roll when people could see Trogarzo approval coming. They will be on a roll again if they get a story that excites people. Honestly outside of us schmucks

[scarlet1967]

The problem with Taimed and THTX in regards to Trogarzo is overselling the drug's financial potentials so the market doesn't take those statements seriously until they produce the goods which I think although nothing close to previous estimates they will be selling more due to better marketing and formulation post pandemic. Now as per sesen and their huge amount followsers I don't